| NCT04334863 |
AflacST1901: Peds WP1066 |
https://ClinicalTrials.gov/show/NCT04334863 |
Recruiting |
Emory University |
2023-07-31 |
| NCT04195555 |
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT04195555 |
Recruiting |
National Cancer Institute (NCI) |
2025-12-31 |
| NCT03698994 |
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03698994 |
Recruiting |
National Cancer Institute (NCI) |
2025-12-31 |
| NCT03526250 |
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03526250 |
Recruiting |
National Cancer Institute (NCI) |
2025-06-30 |
| NCT03299309 |
PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma |
https://ClinicalTrials.gov/show/NCT03299309 |
Recruiting |
Duke University |
2020-12-31 |
| NCT03273712 |
Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) |
https://ClinicalTrials.gov/show/NCT03273712 |
Recruiting |
University of Iowa |
2020-01-31 |
| NCT03257631 |
A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors |
https://ClinicalTrials.gov/show/NCT03257631 |
Active, not recruiting |
Celgene |
2018-11-23 |
| NCT03173950 |
Immune Checkpoint Inhibitor Nivolumab in People With Select Rare CNS Cancers |
https://ClinicalTrials.gov/show/NCT03173950 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-12-31 |
| NCT03043391 |
Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children |
https://ClinicalTrials.gov/show/NCT03043391 |
Recruiting |
Istari Oncology, Inc. |
2020-07-01 |
| NCT03233204 |
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03233204 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02962167 |
Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT |
https://ClinicalTrials.gov/show/NCT02962167 |
Recruiting |
University of California, San Francisco |
2020-11-01 |
| NCT02875314 |
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors |
https://ClinicalTrials.gov/show/NCT02875314 |
Recruiting |
Nationwide Children’s Hospital |
2020-09-30 |
| NCT03213704 |
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213704 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02748135 |
A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma |
https://ClinicalTrials.gov/show/NCT02748135 |
Recruiting |
Oncurious NV |
2022-06-30 |
| NCT02724579 |
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma |
https://ClinicalTrials.gov/show/NCT02724579 |
Recruiting |
Children’s Oncology Group |
2025-05-31 |
| NCT03213678 |
PI3K/mTOR Inhibitor LY3023414 in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213678 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT03213665 |
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213665 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT02644291 |
Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors |
https://ClinicalTrials.gov/show/NCT02644291 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2021-06-30 |
| NCT03213652 |
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03213652 |
Recruiting |
National Cancer Institute (NCI) |
2024-09-30 |
| NCT03210714 |
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) |
https://ClinicalTrials.gov/show/NCT03210714 |
Recruiting |
National Cancer Institute (NCI) |
2024-12-31 |
| NCT03155620 |
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) |
https://ClinicalTrials.gov/show/NCT03155620 |
Recruiting |
National Cancer Institute (NCI) |
2027-09-30 |
| NCT03389802 |
Phase I Study of APX005M in Pediatric CNS Tumors |
https://ClinicalTrials.gov/show/NCT03389802 |
Recruiting |
Pediatric Brain Tumor Consortium |
2020-09-30 |
| NCT00840047 |
Methionine PET/CT Studies In Patients With Cancer |
https://ClinicalTrials.gov/show/NCT00840047 |
Recruiting |
St. Jude Children’s Research Hospital |
2027-07-27 |
| NCT02502708 |
Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors |
https://ClinicalTrials.gov/show/NCT02502708 |
Completed |
Lumos Pharma |
2019-12-12 |
| NCT03387020 |
Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors |
https://ClinicalTrials.gov/show/NCT03387020 |
Completed |
Pediatric Brain Tumor Consortium |
2020-04-01 |
| NCT02444546 |
Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors |
https://ClinicalTrials.gov/show/NCT02444546 |
Active, not recruiting |
Mayo Clinic |
2018-07-13 |
| NCT02441088 |
Theranostics: 68GaDOTATOC and 90YDOTATOC |
https://ClinicalTrials.gov/show/NCT02441088 |
Active, not recruiting |
University of Iowa |
2020-01-31 |
| NCT02441062 |
Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT02441062 |
Completed |
University of Iowa |
2020-01-20 |
| NCT02359565 |
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma |
https://ClinicalTrials.gov/show/NCT02359565 |
Recruiting |
National Cancer Institute (NCI) |
2023-12-31 |
| NCT02271711 |
Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors |
https://ClinicalTrials.gov/show/NCT02271711 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-03-30 |
| NCT02162732 |
Molecular-Guided Therapy for Childhood Cancer |
https://ClinicalTrials.gov/show/NCT02162732 |
Active, not recruiting |
Spectrum Health Hospitals |
2020-06-30 |
| NCT02095132 |
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT02095132 |
Active, not recruiting |
National Cancer Institute (NCI) |
2021-04-30 |
| NCT02066220 |
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma |
https://ClinicalTrials.gov/show/NCT02066220 |
Recruiting |
Universitätsklinikum Hamburg-Eppendorf |
2024-04-30 |
| NCT02040376 |
Placebo Controlled Double Blind Crossover Trial of Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma |
https://ClinicalTrials.gov/show/NCT02040376 |
Completed |
The Hospital for Sick Children |
2017-12-31 |
| NCT02017964 |
Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma |
https://ClinicalTrials.gov/show/NCT02017964 |
Active, not recruiting |
Children’s Oncology Group |
2018-03-31 |
| NCT02025881 |
Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma |
https://ClinicalTrials.gov/show/NCT02025881 |
Recruiting |
Gustave Roussy, Cancer Campus, Grand Paris |
2018-09-30 |
| NCT01977677 |
Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma |
https://ClinicalTrials.gov/show/NCT01977677 |
Completed |
Stanford University |
2017-11-30 |
| NCT01975116 |
p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT01975116 |
Completed |
Pediatric Brain Tumor Consortium |
2015-04-30 |
| NCT01878617 |
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma |
https://ClinicalTrials.gov/show/NCT01878617 |
Recruiting |
St. Jude Children’s Research Hospital |
2023-06-30 |
| NCT01869725 |
Ga-DOTATOC Versus Octreoscan + CT |
https://ClinicalTrials.gov/show/NCT01869725 |
Completed |
University of Iowa |
2018-12-26 |
| NCT01857453 |
Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas |
https://ClinicalTrials.gov/show/NCT01857453 |
Recruiting |
Central Hospital, Nancy, France |
2018-12-31 |
| NCT01802567 |
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer |
https://ClinicalTrials.gov/show/NCT01802567 |
Active, not recruiting |
Spectrum Health Hospitals |
2019-12-31 |
| NCT01708174 |
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB) |
https://ClinicalTrials.gov/show/NCT01708174 |
Completed |
Novartis |
2016-10-05 |
| NCT01619865 |
Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors |
https://ClinicalTrials.gov/show/NCT01619865 |
Active, not recruiting |
University of Iowa |
2017-08-27 |
| NCT01542736 |
Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET) |
https://ClinicalTrials.gov/show/NCT01542736 |
Completed |
University of Colorado, Denver |
2015-11-30 |
| NCT01505569 |
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors |
https://ClinicalTrials.gov/show/NCT01505569 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2021-03-31 |
| NCT01356290 |
Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma |
https://ClinicalTrials.gov/show/NCT01356290 |
Recruiting |
Medical University of Vienna |
2021-04-30 |
| NCT01351870 |
Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma |
https://ClinicalTrials.gov/show/NCT01351870 |
Active, not recruiting |
Institut Curie |
2008-12-31 |
| NCT01326104 |
Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor |
https://ClinicalTrials.gov/show/NCT01326104 |
Active, not recruiting |
University of Florida |
2020-09-30 |
| NCT04315064 |
Infusion of Panobinostat (MTX110) Into the Fourth Ventricle in Children and Adults With Recurrent Medulloblastoma |
https://ClinicalTrials.gov/show/NCT04315064 |
Recruiting |
The University of Texas Health Science Center, Houston |
2022-12-30 |
| NCT04185038 |
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT04185038 |
Recruiting |
Seattle Children’s Hospital |
2026-05-31 |
| NCT04049669 |
Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG |
https://ClinicalTrials.gov/show/NCT04049669 |
Recruiting |
Augusta University |
2024-10-02 |
| NCT04023669 |
Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors |
https://ClinicalTrials.gov/show/NCT04023669 |
Recruiting |
St. Jude Children’s Research Hospital |
2025-06-30 |
| NCT03990597 |
StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord |
https://ClinicalTrials.gov/show/NCT03990597 |
Recruiting |
M.D. Anderson Cancer Center |
2020-05-31 |
| NCT03904862 |
Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery |
https://ClinicalTrials.gov/show/NCT03904862 |
Recruiting |
Pediatric Brain Tumor Consortium |
2022-05-01 |
| NCT03893487 |
Fimepinostat in Treating Brain Tumors in Children and Young Adults |
https://ClinicalTrials.gov/show/NCT03893487 |
Recruiting |
University of California, San Francisco |
2022-06-01 |
| NCT03734913 |
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03734913 |
Recruiting |
Guangdong Zhongsheng Pharmaceutical Co., Ltd. |
2020-11-01 |
| NCT03709680 |
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT03709680 |
Recruiting |
Pfizer |
2021-02-16 |
| NCT03675230 |
Study of Tomotherapy HD in Medulloblastoma |
https://ClinicalTrials.gov/show/NCT03675230 |
Recruiting |
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
2019-05-30 |
| NCT03638167 |
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors |
https://ClinicalTrials.gov/show/NCT03638167 |
Recruiting |
Seattle Children’s Hospital |
2022-03-31 |
| NCT03615404 |
Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma |
https://ClinicalTrials.gov/show/NCT03615404 |
Active, not recruiting |
Duke University |
2019-11-19 |
| NCT03598244 |
Volitinib in Treating Participants With Recurrent or Refractory Primary CNS Tumors |
https://ClinicalTrials.gov/show/NCT03598244 |
Recruiting |
National Cancer Institute (NCI) |
2020-12-31 |
| NCT03500991 |
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors |
https://ClinicalTrials.gov/show/NCT03500991 |
Recruiting |
Seattle Children’s Hospital |
2021-07-26 |
| NCT03434262 |
SJDAWN: St. Jude Children’s Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors |
https://ClinicalTrials.gov/show/NCT03434262 |
Recruiting |
St. Jude Children’s Research Hospital |
2025-02-28 |
| NCT01239316 |
Vismodegib in Treating Younger Patients With Recurrent or Refractory Medulloblastoma |
https://ClinicalTrials.gov/show/NCT01239316 |
Completed |
National Cancer Institute (NCI) |
2014-06-30 |
| NCT01217437 |
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors |
https://ClinicalTrials.gov/show/NCT01217437 |
Active, not recruiting |
National Cancer Institute (NCI) |
2017-12-31 |
| NCT01208831 |
An East Asian Study of LDE225 |
https://ClinicalTrials.gov/show/NCT01208831 |
Completed |
Novartis |
2013-10-31 |
| NCT01171469 |
Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor |
https://ClinicalTrials.gov/show/NCT01171469 |
Completed |
Masonic Cancer Center, University of Minnesota |
2012-05-31 |
| NCT01125800 |
A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB |
https://ClinicalTrials.gov/show/NCT01125800 |
Completed |
Novartis |
2014-10-31 |
| NCT01119599 |
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma |
https://ClinicalTrials.gov/show/NCT01119599 |
Completed |
National Cancer Institute (NCI) |
2013-06-30 |
| NCT01106508 |
A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT01106508 |
Completed |
Novartis |
2015-06-30 |
| NCT01076530 |
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors |
https://ClinicalTrials.gov/show/NCT01076530 |
Completed |
National Cancer Institute (NCI) |
2012-10-31 |
| NCT01063114 |
Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma |
https://ClinicalTrials.gov/show/NCT01063114 |
Active, not recruiting |
Massachusetts General Hospital |
2021-11-30 |
| NCT00994500 |
Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma |
https://ClinicalTrials.gov/show/NCT00994500 |
Completed |
National Cancer Institute (NCI) |
2011-07-31 |
| NCT00994071 |
A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors |
https://ClinicalTrials.gov/show/NCT00994071 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00946335 |
ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors |
https://ClinicalTrials.gov/show/NCT00946335 |
Completed |
National Cancer Institute (NCI) |
2011-10-31 |
| NCT00939484 |
Vismodegib in Treating Patients With Recurrent or Refractory Medulloblastoma |
https://ClinicalTrials.gov/show/NCT00939484 |
Completed |
National Cancer Institute (NCI) |
2013-05-31 |
| NCT00880308 |
Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00880308 |
Completed |
Novartis |
2013-07-31 |
| NCT00867568 |
TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma |
https://ClinicalTrials.gov/show/NCT00867568 |
Completed |
Spectrum Health Hospitals |
2011-09-30 |
| NCT00867178 |
Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System |
https://ClinicalTrials.gov/show/NCT00867178 |
Active, not recruiting |
National Cancer Institute (NCI) |
2018-12-30 |
| NCT00822458 |
GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment |
https://ClinicalTrials.gov/show/NCT00822458 |
Completed |
National Cancer Institute (NCI) |
2013-09-30 |
| NCT01614132 |
Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults |
https://ClinicalTrials.gov/show/NCT01614132 |
Completed |
University of Regensburg |
2018-10-31 |
| NCT01331135 |
Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors |
https://ClinicalTrials.gov/show/NCT01331135 |
Completed |
Emory University |
2017-08-09 |
| NCT03911388 |
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors |
https://ClinicalTrials.gov/show/NCT03911388 |
Recruiting |
University of Alabama at Birmingham |
2023-09-01 |
| NCT00749723 |
Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children |
https://ClinicalTrials.gov/show/NCT00749723 |
Completed |
University Hospital, Bonn |
2015-01-31 |
| NCT00716976 |
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy |
https://ClinicalTrials.gov/show/NCT00716976 |
Completed |
Children’s Oncology Group |
2015-04-30 |
| NCT00601003 |
Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma |
https://ClinicalTrials.gov/show/NCT00601003 |
Active, not recruiting |
Spectrum Health Hospitals |
2020-05-01 |
| NCT00638898 |
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor |
https://ClinicalTrials.gov/show/NCT00638898 |
Active, not recruiting |
City of Hope Medical Center |
2020-09-01 |
| NCT00520936 |
A Study of Pemetrexed in Children With Recurrent Cancer |
https://ClinicalTrials.gov/show/NCT00520936 |
Completed |
Eli Lilly and Company |
2010-02-28 |
| NCT00019578 |
Stereotactic Radiosurgery in Treating Patients With Brain Tumors |
https://ClinicalTrials.gov/show/NCT00019578 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00407433 |
Clinical Studies of Gemcitabine-Oxaliplatin |
https://ClinicalTrials.gov/show/NCT00407433 |
Completed |
Gustave Roussy, Cancer Campus, Grand Paris |
NA |
| NCT00404495 |
Combination of Irinotecan and Temozolomide in Children With Brain Tumors. |
https://ClinicalTrials.gov/show/NCT00404495 |
Completed |
Pfizer |
2011-01-31 |
| NCT00392327 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET |
https://ClinicalTrials.gov/show/NCT00392327 |
Active, not recruiting |
Children’s Oncology Group |
2019-06-30 |
| NCT00381797 |
Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma |
https://ClinicalTrials.gov/show/NCT00381797 |
Completed |
National Cancer Institute (NCI) |
2015-10-31 |
| NCT00326664 |
AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors |
https://ClinicalTrials.gov/show/NCT00326664 |
Completed |
National Cancer Institute (NCI) |
2015-07-31 |
| NCT00363272 |
Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00363272 |
Completed |
National Cancer Institute (NCI) |
2008-10-31 |
| NCT00336024 |
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma |
https://ClinicalTrials.gov/show/NCT00336024 |
Active, not recruiting |
Children’s Oncology Group |
2016-12-31 |
| NCT00303810 |
Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma |
https://ClinicalTrials.gov/show/NCT00303810 |
Completed |
Universitätsklinikum Hamburg-Eppendorf |
2013-12-31 |
| NCT00217412 |
Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia |
https://ClinicalTrials.gov/show/NCT00217412 |
Completed |
National Cancer Institute (NCI) |
2009-09-30 |
| NCT00105560 |
Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma |
https://ClinicalTrials.gov/show/NCT00105560 |
Active, not recruiting |
Massachusetts General Hospital |
2012-12-31 |
| NCT00101270 |
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00101270 |
Completed |
National Cancer Institute (NCI) |
2007-09-30 |
| NCT00100880 |
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors |
https://ClinicalTrials.gov/show/NCT00100880 |
Completed |
National Cancer Institute (NCI) |
2010-11-30 |
| NCT00095940 |
Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors |
https://ClinicalTrials.gov/show/NCT00095940 |
Completed |
National Cancer Institute (NCI) |
2010-07-31 |
| NCT00085735 |
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma |
https://ClinicalTrials.gov/show/NCT00085735 |
Active, not recruiting |
Children’s Oncology Group |
2016-03-31 |
| NCT00085202 |
Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
https://ClinicalTrials.gov/show/NCT00085202 |
Active, not recruiting |
St. Jude Children’s Research Hospital |
2016-12-31 |
| NCT00002875 |
Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma |
https://ClinicalTrials.gov/show/NCT00002875 |
Completed |
Children’s Oncology Group |
2006-02-28 |
| NCT00003573 |
Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma |
https://ClinicalTrials.gov/show/NCT00003573 |
Completed |
Children’s Oncology Group |
2007-10-31 |
| NCT00077454 |
Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00077454 |
Completed |
National Cancer Institute (NCI) |
2007-09-30 |
| NCT00070525 |
Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma |
https://ClinicalTrials.gov/show/NCT00070525 |
Completed |
National Cancer Institute (NCI) |
2006-09-30 |
| NCT00063973 |
Cilengitide in Treating Children With Refractory Primary Brain Tumors |
https://ClinicalTrials.gov/show/NCT00063973 |
Completed |
National Cancer Institute (NCI) |
2008-03-31 |
| NCT00003211 |
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
https://ClinicalTrials.gov/show/NCT00003211 |
Completed |
St. Jude Children’s Research Hospital |
2007-06-30 |
| NCT00058370 |
Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma |
https://ClinicalTrials.gov/show/NCT00058370 |
Completed |
Memorial Sloan Kettering Cancer Center |
2019-06-30 |
| NCT00053963 |
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia |
https://ClinicalTrials.gov/show/NCT00053963 |
Completed |
National Cancer Institute (NCI) |
2006-02-28 |
| NCT00004078 |
Irinotecan in Treating Children With Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00004078 |
Completed |
Children’s Oncology Group |
2007-10-31 |
| NCT00052780 |
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors |
https://ClinicalTrials.gov/show/NCT00052780 |
Completed |
National Cancer Institute (NCI) |
2007-11-30 |
| NCT00047177 |
Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
https://ClinicalTrials.gov/show/NCT00047177 |
Completed |
Pediatric Brain Tumor Consortium |
2004-08-31 |
| NCT00025077 |
Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors |
https://ClinicalTrials.gov/show/NCT00025077 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00012181 |
Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00012181 |
Completed |
National Cancer Institute (NCI) |
2005-01-31 |
| NCT00006461 |
Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor |
https://ClinicalTrials.gov/show/NCT00006461 |
Completed |
Children’s Oncology Group |
2007-09-30 |
| NCT00005811 |
Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment |
https://ClinicalTrials.gov/show/NCT00005811 |
Completed |
National Cancer Institute (NCI) |
2006-04-30 |
| NCT00003309 |
Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer |
https://ClinicalTrials.gov/show/NCT00003309 |
Completed |
Eastern Cooperative Oncology Group |
2004-03-31 |
| NCT00002594 |
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors |
https://ClinicalTrials.gov/show/NCT00002594 |
Completed |
Children’s Oncology Group |
2003-09-30 |
| NCT00001502 |
A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors |
https://ClinicalTrials.gov/show/NCT00001502 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00006258 |
Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma |
https://ClinicalTrials.gov/show/NCT00006258 |
Completed |
National Cancer Institute (NCI) |
NA |